Skip to main content
Top
Published in: Tobacco Induced Diseases 1/2015

Open Access 01-12-2015 | Research

Comparison between cigarette smoke-induced emphysema and cigarette smoke extract-induced emphysema

Authors: Zhi-Hui He, Ping Chen, Yan Chen, Sheng-Dong He, Ji-Ru Ye, Hong-Liang Zhang, Jun Cao

Published in: Tobacco Induced Diseases | Issue 1/2015

Login to get access

Abstract

Background and objective

Emphysema is the main pathological feature of COPD and also is the focus of the related research. Although several emphysema animal models have been established, exact comparison of findings is seldom. The present study aimed to compare cigarette smoke (CS) exposure-induced emphysema model and intraperitoneal injection of cigarette smoke extract (CSE)-induced emphysema model to evaluate the effectiveness of the two different modeling methods.

Methods

Six-week-old male C57BL/6 J mice were used and randomly divided into two groups: CS exposure and intraperitoneal injection of CSE. Each group was subdivided into two subgroups: control and CS or CSE. Lung function, mean linear intercept (MLI), destructive index (DI), apoptotic index (AI), total and differential cells count in broncholavolar lavage fluid (BALF), SOD and IL-6 concentration in serum were measured.

Results

Compared with their respective controls, lung function was significantly decreased in CS and CSE groups (P < 0.01); MLI, DI, and AI of lung tissue were significantly higher in CS and CSE groups (P < 0.01); total number of leukocytes, the number and percentage of neutrophils (NEUs), and the number of macrophages (MAC) in BALF were significantly higher in CS and CSE groups (P < 0.01); SOD concentration in serum was significantly decreased in CS and CSE groups (P < 0.01); IL-6 concentration in serum was significantly increased in in CS and CSE groups (P < 0.01). There was no significant difference between CS group and CSE group in any of the parameters described above.

Conclusions

Both CS exposure and intraperitoneal injection of CSE could induce emphysema and the effectiveness of the two different modeling methods were equal.
Literature
1.
go back to reference Fuschillo S, Martucci M, Donner CF, Balzano G. Airway bacterial colonization: the missing link between COPD and cardiovascular events? Respir Med. 2012;106:915–23.CrossRefPubMed Fuschillo S, Martucci M, Donner CF, Balzano G. Airway bacterial colonization: the missing link between COPD and cardiovascular events? Respir Med. 2012;106:915–23.CrossRefPubMed
2.
go back to reference Miravitlles M. Cough and sputum production as risk factors for poor outcomes in patients with COPD. Respir Med. 2011;105:1118–28.CrossRefPubMed Miravitlles M. Cough and sputum production as risk factors for poor outcomes in patients with COPD. Respir Med. 2011;105:1118–28.CrossRefPubMed
3.
go back to reference Pryor WA, Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci. 1993;686:12–27.CrossRefPubMed Pryor WA, Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci. 1993;686:12–27.CrossRefPubMed
4.
go back to reference Xu CB, Lei Y, Chen Q, Pehrson C, Larsson L, Edvinsson L. Cigarette smoke extracts promote vascular smooth muscle cell proliferation and enhances contractile responses in the vasculature and airway. Basic Clin Pharmacol Toxicol. 2010;107:940–8.CrossRefPubMed Xu CB, Lei Y, Chen Q, Pehrson C, Larsson L, Edvinsson L. Cigarette smoke extracts promote vascular smooth muscle cell proliferation and enhances contractile responses in the vasculature and airway. Basic Clin Pharmacol Toxicol. 2010;107:940–8.CrossRefPubMed
5.
go back to reference Zhang H, Chen P, Zeng H, Zhang Y, Peng H, Chen Y, et al. Protective effect of demethylation treatment on cigarette smoke extract-induced mouse emphysema model. J Pharmacol Sci. 2013;123:159–66.CrossRefPubMed Zhang H, Chen P, Zeng H, Zhang Y, Peng H, Chen Y, et al. Protective effect of demethylation treatment on cigarette smoke extract-induced mouse emphysema model. J Pharmacol Sci. 2013;123:159–66.CrossRefPubMed
6.
go back to reference He S, He Z, Chen Y, Ye J, Zong D, Zhang Y, et al. C-Kit/c-Kit ligand interaction of bone marrow endothelial progenitor cells is influenced in acigarette smoke extract-induced emphysema model. Exp Lung Res. 2013;39:258–67.CrossRefPubMed He S, He Z, Chen Y, Ye J, Zong D, Zhang Y, et al. C-Kit/c-Kit ligand interaction of bone marrow endothelial progenitor cells is influenced in acigarette smoke extract-induced emphysema model. Exp Lung Res. 2013;39:258–67.CrossRefPubMed
7.
go back to reference World Medical Association; American Physiological Society. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol. 2002;283:R281–3.CrossRef World Medical Association; American Physiological Society. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol. 2002;283:R281–3.CrossRef
8.
go back to reference Chen Y, Hanaoka M, Droma Y, Chen P, Voelkel NF, Kubo K. Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats. Eur Respir J. 2010;35:904–12.CrossRefPubMed Chen Y, Hanaoka M, Droma Y, Chen P, Voelkel NF, Kubo K. Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats. Eur Respir J. 2010;35:904–12.CrossRefPubMed
9.
go back to reference Zhang Y, Cao J, Chen Y, Chen P, Peng H, Cai S, et al. Intraperitoneal injection of cigarette smoke extract induced emphysema, and injury of cardiac and skeletal muscles in BALB/C mice. Exp Lung Res. 2013;39:18–31.CrossRefPubMed Zhang Y, Cao J, Chen Y, Chen P, Peng H, Cai S, et al. Intraperitoneal injection of cigarette smoke extract induced emphysema, and injury of cardiac and skeletal muscles in BALB/C mice. Exp Lung Res. 2013;39:18–31.CrossRefPubMed
10.
go back to reference Yao H, Chung S, Hwang JW, Rajendrasozhan S, Sundar IK, Dean DA, et al. SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J Clin Invest. 2012;122:2032–45.CrossRefPubMedCentralPubMed Yao H, Chung S, Hwang JW, Rajendrasozhan S, Sundar IK, Dean DA, et al. SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J Clin Invest. 2012;122:2032–45.CrossRefPubMedCentralPubMed
11.
go back to reference Chen Y, Hanaoka M, Chen P, Droma Y, Voelkel NF, Kubo K. Protective effect of beraprost sodium, a stable prostacyclin analog, in the development of cigarette smoke extract-induced emphysema. Am J Physiol Lung Cell Mol Physiol. 2009;296:L648–56.CrossRefPubMed Chen Y, Hanaoka M, Chen P, Droma Y, Voelkel NF, Kubo K. Protective effect of beraprost sodium, a stable prostacyclin analog, in the development of cigarette smoke extract-induced emphysema. Am J Physiol Lung Cell Mol Physiol. 2009;296:L648–56.CrossRefPubMed
12.
go back to reference Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonarydisease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–65.CrossRefPubMed Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonarydisease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–65.CrossRefPubMed
14.
go back to reference Ochs M. Estimating structural alterations in animal models of lung emphysema. Is there a gold standard? Ann Anat. 2014;196:26–33.CrossRefPubMed Ochs M. Estimating structural alterations in animal models of lung emphysema. Is there a gold standard? Ann Anat. 2014;196:26–33.CrossRefPubMed
15.
go back to reference American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152:S77–121. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152:S77–121.
16.
go back to reference Yang Q, Underwood MJ, Hsin MK, Liu XC, He GW. Dysfunction of pulmonary vascular endothelium in chronic obstructive pulmonary disease: basic considerations for future drug development. Curr Drug Metab. 2008;9:661–7.CrossRefPubMed Yang Q, Underwood MJ, Hsin MK, Liu XC, He GW. Dysfunction of pulmonary vascular endothelium in chronic obstructive pulmonary disease: basic considerations for future drug development. Curr Drug Metab. 2008;9:661–7.CrossRefPubMed
17.
go back to reference He Z, Chen Y, Chen P, Wu G, Cai S. Local inflammation occurs before systemic inflammation in patients with COPD. Respirology. 2010;15:478–84.CrossRefPubMed He Z, Chen Y, Chen P, Wu G, Cai S. Local inflammation occurs before systemic inflammation in patients with COPD. Respirology. 2010;15:478–84.CrossRefPubMed
18.
go back to reference Yao H, Rahman I. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicol Appl Pharmacol. 2011;254:72–85.CrossRefPubMedCentralPubMed Yao H, Rahman I. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicol Appl Pharmacol. 2011;254:72–85.CrossRefPubMedCentralPubMed
19.
go back to reference Hillas G, Nikolakopoulou S, Hussain S, Vassilakopoulos T. Antioxidants and mucolytics in COPD management: when (if ever) and in whom? Curr Drug Targets. 2013;14:225–34.CrossRefPubMed Hillas G, Nikolakopoulou S, Hussain S, Vassilakopoulos T. Antioxidants and mucolytics in COPD management: when (if ever) and in whom? Curr Drug Targets. 2013;14:225–34.CrossRefPubMed
20.
go back to reference Yao H, Arunachalam G, Hwang JW, Chung S, Sundar IK, Kinnula VL, et al. Extracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECM. Proc Natl Acad Sci U S A. 2010;107:15571–6.CrossRefPubMedCentralPubMed Yao H, Arunachalam G, Hwang JW, Chung S, Sundar IK, Kinnula VL, et al. Extracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECM. Proc Natl Acad Sci U S A. 2010;107:15571–6.CrossRefPubMedCentralPubMed
21.
go back to reference Biffl WL, Moore EE, Moore FA, Barnett Jr CC, Carl VS, Peterson VN. Interleukin-6 delays neutrophil apoptosis. Arch Surg. 1996;131:24–30.CrossRefPubMed Biffl WL, Moore EE, Moore FA, Barnett Jr CC, Carl VS, Peterson VN. Interleukin-6 delays neutrophil apoptosis. Arch Surg. 1996;131:24–30.CrossRefPubMed
22.
go back to reference Yanbaeva DG, Dentener MA, Spruit MA, Houwing-Duistermaat JJ, Kotz D, Passos VL, et al. IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case–control study. BMC Med Genet. 2009;10:23.CrossRefPubMedCentralPubMed Yanbaeva DG, Dentener MA, Spruit MA, Houwing-Duistermaat JJ, Kotz D, Passos VL, et al. IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case–control study. BMC Med Genet. 2009;10:23.CrossRefPubMedCentralPubMed
23.
go back to reference Ruwanpura SM, McLeod L, Miller A, Jones J, Bozinovski S, Vlahos R, et al. Interleukin-6 promotes pulmonary emphysema associated with apoptosis in mice. Am J Respir Cell Mol Biol. 2011;45:720–30.CrossRefPubMed Ruwanpura SM, McLeod L, Miller A, Jones J, Bozinovski S, Vlahos R, et al. Interleukin-6 promotes pulmonary emphysema associated with apoptosis in mice. Am J Respir Cell Mol Biol. 2011;45:720–30.CrossRefPubMed
24.
go back to reference Bozinovski S, Hutchinson A, Thompson M, Macgregor L, Black J, Giannakis E, et al. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177:269–78.CrossRefPubMed Bozinovski S, Hutchinson A, Thompson M, Macgregor L, Black J, Giannakis E, et al. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177:269–78.CrossRefPubMed
25.
go back to reference Martin JG, Tamaoka M. Rat models of asthma and chronic obstructive lung disease. Pulm Pharmacol Ther. 2006;19:377–85.CrossRefPubMed Martin JG, Tamaoka M. Rat models of asthma and chronic obstructive lung disease. Pulm Pharmacol Ther. 2006;19:377–85.CrossRefPubMed
26.
go back to reference Brusselle GG, Bracke KR, Maes T, D’hulst AI, Moerloose KB, Joos GF, et al. Murine models of COPD. Pulm Pharmacol Ther. 2006;19:155–65.CrossRefPubMed Brusselle GG, Bracke KR, Maes T, D’hulst AI, Moerloose KB, Joos GF, et al. Murine models of COPD. Pulm Pharmacol Ther. 2006;19:155–65.CrossRefPubMed
27.
go back to reference Plopper CG, Hyde DM. The non-human primate as a model for studying COPD and asthma. Pulm Pharmacol Ther. 2008;21:755–66.CrossRefPubMed Plopper CG, Hyde DM. The non-human primate as a model for studying COPD and asthma. Pulm Pharmacol Ther. 2008;21:755–66.CrossRefPubMed
29.
go back to reference Abraham WM. Modeling of asthma, COPD and cystic fibrosis in sheep. Pulm Pharmacol Ther. 2008;21:743–54.CrossRefPubMed Abraham WM. Modeling of asthma, COPD and cystic fibrosis in sheep. Pulm Pharmacol Ther. 2008;21:743–54.CrossRefPubMed
30.
31.
go back to reference Wright JL, Churg A. Animal models of cigarette smoke-induced COPD. Chest. 2002;122(6 suppl):S301–6.CrossRef Wright JL, Churg A. Animal models of cigarette smoke-induced COPD. Chest. 2002;122(6 suppl):S301–6.CrossRef
32.
go back to reference Givi ME, Peck MJ, Boon L, Mortaz E. The role of dendritic cells in the pathogenesis of cigarette smoke-induced emphysema in mice. Eur J Pharmacol. 2013;721:259–66.CrossRefPubMed Givi ME, Peck MJ, Boon L, Mortaz E. The role of dendritic cells in the pathogenesis of cigarette smoke-induced emphysema in mice. Eur J Pharmacol. 2013;721:259–66.CrossRefPubMed
33.
go back to reference Longhini-Dos-Santos N, Barbosa-de-Oliveira VA, Kozma RH, Faria CA, Stessuk T, Frei F, et al. Cell therapy with bone marrow mononuclear cells in elastase-induced pulmonary emphysema. Stem Cell Rev. 2013;9:210–8.CrossRefPubMed Longhini-Dos-Santos N, Barbosa-de-Oliveira VA, Kozma RH, Faria CA, Stessuk T, Frei F, et al. Cell therapy with bone marrow mononuclear cells in elastase-induced pulmonary emphysema. Stem Cell Rev. 2013;9:210–8.CrossRefPubMed
34.
go back to reference Pera T, Zuidhof AB, Smit M, Menzen MH, Klein T, Flik G, et al. Arginase inhibition prevents inflammation and remodeling in a guinea pig model of chronic obstructive pulmonary disease. J Pharmacol Exp Ther. 2014;349:229–38.CrossRefPubMed Pera T, Zuidhof AB, Smit M, Menzen MH, Klein T, Flik G, et al. Arginase inhibition prevents inflammation and remodeling in a guinea pig model of chronic obstructive pulmonary disease. J Pharmacol Exp Ther. 2014;349:229–38.CrossRefPubMed
35.
go back to reference Wagner U, Staats P, Fehmann HC, Fischer A, Welte T, Groneberg DA. Analysis of airway secretions in a model of sulfur dioxide induced chronic obstructive pulmonary disease (COPD). J Occup Med Toxicol. 2006;1:12.CrossRefPubMedCentralPubMed Wagner U, Staats P, Fehmann HC, Fischer A, Welte T, Groneberg DA. Analysis of airway secretions in a model of sulfur dioxide induced chronic obstructive pulmonary disease (COPD). J Occup Med Toxicol. 2006;1:12.CrossRefPubMedCentralPubMed
36.
go back to reference Misaka S, Sato H, Yamauchi Y, Onoue S, Yamada S. Novel dry powder formulation of ovalbumin for development of COPD-like animal model: physicochemical characterization and biomarker profiling in rats. Eur J Pharm Sci. 2009;37:469–76.CrossRefPubMed Misaka S, Sato H, Yamauchi Y, Onoue S, Yamada S. Novel dry powder formulation of ovalbumin for development of COPD-like animal model: physicochemical characterization and biomarker profiling in rats. Eur J Pharm Sci. 2009;37:469–76.CrossRefPubMed
37.
go back to reference Tazaki G, Kondo T, Tajiri S, Tsuji C, Shioya S, Tanigaki T. Functional residual capacity and airway resistance in rats of COPD model induced by systemic hyaluronidase. Tokai J Exp Clin Med. 2006;31:125–7.PubMed Tazaki G, Kondo T, Tajiri S, Tsuji C, Shioya S, Tanigaki T. Functional residual capacity and airway resistance in rats of COPD model induced by systemic hyaluronidase. Tokai J Exp Clin Med. 2006;31:125–7.PubMed
38.
go back to reference Baron RM, Choi AJ, Owen CA, Choi AM. Genetically manipulated mouse models of lung disease: potential and pitfalls. Am J Physiol Lung Cell Mol Physiol. 2012;302:L485–97.CrossRefPubMedCentralPubMed Baron RM, Choi AJ, Owen CA, Choi AM. Genetically manipulated mouse models of lung disease: potential and pitfalls. Am J Physiol Lung Cell Mol Physiol. 2012;302:L485–97.CrossRefPubMedCentralPubMed
39.
go back to reference Taraseviciene-Stewart L, Scerbavicius R, Choe KH, Moore M, Sullivan A, Nicolls MR, et al. An animal model of autoimmune emphysema. Am J Respir Crit Care Med. 2005;171:734–42.CrossRefPubMed Taraseviciene-Stewart L, Scerbavicius R, Choe KH, Moore M, Sullivan A, Nicolls MR, et al. An animal model of autoimmune emphysema. Am J Respir Crit Care Med. 2005;171:734–42.CrossRefPubMed
40.
41.
go back to reference Jeong YY, Park HJ, Cho YW, Kim EJ, Kim GT, Mun YJ, et al. Aged red garlic extract reduces cigarette smoke extract-induced cell death in human bronchial smooth muscle cells by increasing intracellular glutathione levels. Phytother Res. 2012;26:18–25.CrossRefPubMed Jeong YY, Park HJ, Cho YW, Kim EJ, Kim GT, Mun YJ, et al. Aged red garlic extract reduces cigarette smoke extract-induced cell death in human bronchial smooth muscle cells by increasing intracellular glutathione levels. Phytother Res. 2012;26:18–25.CrossRefPubMed
42.
go back to reference Tzortzaki EG, Papi A, Neofytou E, Soulitzis N, Siafakas NM. Immune and genetic mechanisms in COPD: possible targets for therapeutic interventions. Curr Drug Targets. 2013;14:141–8.CrossRefPubMed Tzortzaki EG, Papi A, Neofytou E, Soulitzis N, Siafakas NM. Immune and genetic mechanisms in COPD: possible targets for therapeutic interventions. Curr Drug Targets. 2013;14:141–8.CrossRefPubMed
43.
go back to reference He ZH, Chen P, Chen Y, Zhu YQ, He SD, Ye JR, et al. Dual effects of cigarette smoke extract on proliferation of endothelial progenitor cells and the protective effect of 5-aza-2’-deoxycytidine on EPCs against the damage caused by CSE. BioMed Res Int. 2014;2014:640752.PubMedCentralPubMed He ZH, Chen P, Chen Y, Zhu YQ, He SD, Ye JR, et al. Dual effects of cigarette smoke extract on proliferation of endothelial progenitor cells and the protective effect of 5-aza-2’-deoxycytidine on EPCs against the damage caused by CSE. BioMed Res Int. 2014;2014:640752.PubMedCentralPubMed
44.
go back to reference Nana-Sinkam SP, Lee JD, Sotto-Santiago S, Stearman RS, Keith RL, Choudhury Q, et al. Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke. Am J Respir Crit Care Med. 2007;175:676–85.CrossRefPubMedCentralPubMed Nana-Sinkam SP, Lee JD, Sotto-Santiago S, Stearman RS, Keith RL, Choudhury Q, et al. Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke. Am J Respir Crit Care Med. 2007;175:676–85.CrossRefPubMedCentralPubMed
45.
go back to reference Taraseviciene-Stewart L, Kraskauskas D, Lee JH, Hanaoka M, Burns N, Parr J, et al. Cigarette smoke extract (CSE)-induced emphysema in mice. Am J Respir Crit Care Med. 2007;175:A529.CrossRef Taraseviciene-Stewart L, Kraskauskas D, Lee JH, Hanaoka M, Burns N, Parr J, et al. Cigarette smoke extract (CSE)-induced emphysema in mice. Am J Respir Crit Care Med. 2007;175:A529.CrossRef
46.
go back to reference Yao H, Edirisinghe I, Rajendrasozhan S, Yang SR, Caito S, Adenuga D, et al. Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice. Am J Physiol Lung Cell Mol Physiol. 2008;294:L1174–86.CrossRefPubMed Yao H, Edirisinghe I, Rajendrasozhan S, Yang SR, Caito S, Adenuga D, et al. Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice. Am J Physiol Lung Cell Mol Physiol. 2008;294:L1174–86.CrossRefPubMed
Metadata
Title
Comparison between cigarette smoke-induced emphysema and cigarette smoke extract-induced emphysema
Authors
Zhi-Hui He
Ping Chen
Yan Chen
Sheng-Dong He
Ji-Ru Ye
Hong-Liang Zhang
Jun Cao
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Tobacco Induced Diseases / Issue 1/2015
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/s12971-015-0033-z

Other articles of this Issue 1/2015

Tobacco Induced Diseases 1/2015 Go to the issue